By Muhammad Basir Roslan
KUALA LUMPUR (Bernama) – Non-communicable diseases (NCDs) are among the leading causes of death in many countries.
NCDs are medical conditions or diseases that are not infectious and these include heart disease, diabetes, hypertension, chronic lung disease and cancer.
It is also an established fact that people with underlying health conditions, such as NCDs, have a higher risk of developing severe COVID-19 and are more likely to succumb to this highly contagious disease.
KUALA LUMPUR, Feb 16 -- Prime Minister Tan Sri Muhyiddin Yassin will launch the National COVID-19 Immunisation Programme Handbook, which contains information on the largest ever vaccination programme ever implemented in the country, today.
GEORGE TOWN, Feb 15 -- The public, particularly Muslims, should not doubt the status of the COVID-19 vaccine, as the muzakarah (discussion) of the Fatwa Committee of the National Council for Islamic Religious Affairs (MKI) has decided that the use of the COVID-19 vaccine is permissible (harus) and obligatory (wajib) for groups which have been identified by the government.
KUALA LUMPUR, Feb 14 -- The COVID-19 vaccines procured by Malaysia are safe and effective and do not contain microchips that will control people’s minds said Science, Technology and Innovation Minister Khairy Jamaluddin.
By Nadia Jumri
KUALA LUMPUR (Bernama) – It is common knowledge that the human immunodeficiency virus or HIV is transmitted mostly through unprotected sex and injection drug use.
In Malaysia, according to recent data released by the Ministry of Health, HIV transmissions among men who have sex with men (MSM) constituted 94 percent of the new 3,564 HIV infections reported in 2019.
Universiti Malaya Specialist Centre (UMSC) infectious disease consultant Associate Prof Dr Raja Iskandar Shah Raja Azwa said there has been a shift in HIV epidemiology over the past decade from injection drug use to sexual transmissions, and more recently among MSM.
By Durratul Ain Ahmad Fuad
KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.
ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.
Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.
By Nadia Jumri
KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.
In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.
Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.read more ››
Pandangan rakyat Malaysia tentang peningkatan sasaran pemberian vaksin COVID-19 kepada 70 peratus.